BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11306568)

  • 1. An essential role for Mad homology domain 1 in the association of Smad3 with histone deacetylase activity*.
    Liberati NT; Moniwa M; Borton AJ; Davie JR; Wang XF
    J Biol Chem; 2001 Jun; 276(25):22595-603. PubMed ID: 11306568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.
    Akiyoshi S; Inoue H; Hanai J; Kusanagi K; Nemoto N; Miyazono K; Kawabata M
    J Biol Chem; 1999 Dec; 274(49):35269-77. PubMed ID: 10575014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
    Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
    J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3).
    Long J; Wang G; Matsuura I; He D; Liu F
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):99-104. PubMed ID: 14691252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of Smad2 and Smad3 transactivating activity by association with a novel splice variant of CCAAT-binding factor C subunit.
    Chen F; Ogawa K; Liu X; Stringfield TM; Chen Y
    Biochem J; 2002 Jun; 364(Pt 2):571-7. PubMed ID: 12023901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
    Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
    J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT.
    Long J; Matsuura I; He D; Wang G; Shuai K; Liu F
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9791-6. PubMed ID: 12904571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ski and SnoN: antagonistic proteins of TGFbeta signaling].
    Vignais ML
    Bull Cancer; 2000 Feb; 87(2):135-7. PubMed ID: 10705283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
    Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ski co-repressor complexes maintain the basal repressed state of the TGF-beta target gene, SMAD7, via HDAC3 and PRMT5.
    Tabata T; Kokura K; Ten Dijke P; Ishii S
    Genes Cells; 2009 Jan; 14(1):17-28. PubMed ID: 19032343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cited2 modulates TGF-beta-mediated upregulation of MMP9.
    Chou YT; Wang H; Chen Y; Danielpour D; Yang YC
    Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interaction between Smad, CREB binding protein, and p68 RNA helicase.
    Warner DR; Bhattacherjee V; Yin X; Singh S; Mukhopadhyay P; Pisano MM; Greene RM
    Biochem Biophys Res Commun; 2004 Nov; 324(1):70-6. PubMed ID: 15464984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional characterization of the transforming growth factor-beta -induced Smad3/c-Jun transcriptional cooperativity.
    Qing J; Zhang Y; Derynck R
    J Biol Chem; 2000 Dec; 275(49):38802-12. PubMed ID: 10995748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation.
    Harada J; Kokura K; Kanei-Ishii C; Nomura T; Khan MM; Kim Y; Ishii S
    J Biol Chem; 2003 Oct; 278(40):38998-9005. PubMed ID: 12874272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
    Yuan W; Varga J
    J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator.
    Billin AN; Thirlwell H; Ayer DE
    Mol Cell Biol; 2000 Sep; 20(18):6882-90. PubMed ID: 10958684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-beta-dependent transcription.
    Leong GM; Subramaniam N; Figueroa J; Flanagan JL; Hayman MJ; Eisman JA; Kouzmenko AP
    J Biol Chem; 2001 May; 276(21):18243-8. PubMed ID: 11278756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of a transcriptional cross talk between transforming growth factor-beta-regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4.
    Chou WC; Prokova V; Shiraishi K; Valcourt U; Moustakas A; Hadzopoulou-Cladaras M; Zannis VI; Kardassis D
    Mol Biol Cell; 2003 Mar; 14(3):1279-94. PubMed ID: 12631740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
    He J; Tegen SB; Krawitz AR; Martin GS; Luo K
    J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling.
    Imoto S; Sugiyama K; Sekine Y; Matsuda T
    FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.